ArticleTrials2022

Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial.

Sibylle Kautz-Freimuth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.